Levitee Labs Stock Fundamentals
| LVTTF Stock | USD 0 0.00 0.00% |
Levitee Labs fundamentals help investors to digest information that contributes to Levitee Labs' financial success or failures. It also enables traders to predict the movement of Levitee Pink Sheet. The fundamental analysis module provides a way to measure Levitee Labs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Levitee Labs pink sheet.
Levitee |
Levitee Labs Company Shares Outstanding Analysis
Levitee Labs' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Levitee Labs Shares Outstanding | 100.42 M |
Most of Levitee Labs' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Levitee Labs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Levitee Labs has 100.42 M of shares currently outstending. This is 44.38% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all United States stocks is 82.44% higher than that of the company.
Levitee Labs Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Levitee Labs's current stock value. Our valuation model uses many indicators to compare Levitee Labs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Levitee Labs competition to find correlations between indicators driving Levitee Labs's intrinsic value. More Info.Levitee Labs is rated below average in current valuation category among its peers. It also is rated below average in shares outstanding category among its peers creating about 44.22 of Shares Outstanding per Current Valuation. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Levitee Labs' earnings, one of the primary drivers of an investment's value.Levitee Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Levitee Labs' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Levitee Labs could also be used in its relative valuation, which is a method of valuing Levitee Labs by comparing valuation metrics of similar companies.Levitee Labs is currently under evaluation in shares outstanding category among its peers.
Levitee Fundamentals
| Current Valuation | 2.27 M | |||
| Shares Outstanding | 100.42 M | |||
| Shares Owned By Insiders | 37.49 % | |||
| Price To Book | 0.09 X | |||
| Price To Sales | 0.05 X | |||
| Revenue | 1.72 M | |||
| EBITDA | (10.73 M) | |||
| Net Income | (11.4 M) | |||
| Cash Flow From Operations | (4.63 M) | |||
| Market Capitalization | 401.67 K | |||
| Total Asset | 12.97 M | |||
| Net Asset | 12.97 M |
About Levitee Labs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Levitee Labs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Levitee Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Levitee Labs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Levitee Labs Inc., a multidisciplinary integrative wellness company, provides evidence-based alternative medicines and novel psychedelic therapies. Levitee Labs Inc. was incorporated in 2019 and is based in Vancouver, Canada. Levitee Labs is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Levitee Pink Sheet
Levitee Labs financial ratios help investors to determine whether Levitee Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Levitee with respect to the benefits of owning Levitee Labs security.